Participation of superoxide anions at the prostaglandin phase of carrageenan foot-oedema.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001565:Benzoates / Q000494:pharmacology; D002351:Carrageenan / Q000037:antagonists & inhibitors; D002374:Catalase / Q000494:pharmacology; D004487:Edema / Q000139:chemically induced / Q000503:physiopathology*; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D008297:Male; D008345:Manganese / Q000494:pharmacology; D008353:Mannitol / Q000494:pharmacology; D008727:Methotrexate / Q000494:pharmacology; D010100:Oxygen / Q000502:physiology*; D011453:Prostaglandins / Q000502:physiology*; D051381:Rats; D012702:Serotonin Antagonists; D013482:Superoxide Dismutase / Q000494:pharmacology; D013481:Superoxides / Q000502:physiology*; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D001565:Benzoates; D006634:Histamine H1 Antagonists; D011453:Prostaglandins; D012702:Serotonin Antagonists; D013481:Superoxides; D008353:Mannitol; D008345:Manganese; D002351:Carrageenan; D002374:Catalase; D013482:Superoxide Dismutase; D010100:Oxygen; D008727:Methotrexate